Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells

Y. S. Guo, Courtney Townsend, G. F. Jin, R. D. Beauchamp, J. C. Thompson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The purposes of this study were to determine the regulation of insulin- like growth factor binding protein-2 (IGFBP-2) in IEC-6 cells by transforming growth factor-β1 (TGF-β1) and insulin and to determine whether IGFBP-2 mediated the growth-inhibitory action on the cells. Utilizing Western ligand blot analysis, we found that TGF-β1 at concentrations of 0.5, 1.0, and 2 ng/ml significantly increased levels of 32-kDa IGFBP in the conditioned medium (CM) of IEC-6 cells in a dose-dependent fashion and that low doses of insulin (1.0 and 5.0 μg/ml) also increased IGFBP levels in the CM of IEC-6 cells, but a high dose of insulin (10 μg/ml) depressed IGFBP release in the CM. Immunoblotting has shown that the IGFBP of 32 kDa was IGFBP-2 and further confirmed the above results. IGFBP-2 mRNA levels were stimulated by TGF-β1 (2.0 ng/ml) and suppressed by insulin (5.0 μg/ml). In addition, des (1-3) IGF-I (50 ng/ml) and insulin stimulated the proliferation of IEC-6 cells. Anti-IGFBP-2 antibodies partially blocked the inhibitory role in IEC-6 cell growth evoked by des (1-3) IGF-I. These findings suggest that the upregulation of IGFBP-2 by TGF-β1 occurs, at least in part, at the level of mRNA, whereas the regulation by insulin appears to be at a posttranslational level, and that the TGF-β1-stimulated production of IGFBP may contribute to the growth-inhibitory action in intestinal epithelial cells.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume268
Issue number6 31-6
StatePublished - 1995

Fingerprint

Insulin-Like Growth Factor Binding Protein 2
transforming growth factors
insulin-like growth factor binding proteins
Transforming Growth Factors
Insulin-Like Growth Factor Binding Proteins
insulin
Insulin
Conditioned Culture Medium
cells
Growth
Messenger RNA
insulin-like growth factor I
Cell growth
Immunoblotting
dosage
Up-Regulation
Western Blotting
Epithelial Cells
Ligands
Antibodies

Keywords

  • transforming growth factor-β1

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Agricultural and Biological Sciences(all)

Cite this

Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells. / Guo, Y. S.; Townsend, Courtney; Jin, G. F.; Beauchamp, R. D.; Thompson, J. C.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 268, No. 6 31-6, 1995.

Research output: Contribution to journalArticle

@article{7cc60993631245cd93536ddaa9ffbe5f,
title = "Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells",
abstract = "The purposes of this study were to determine the regulation of insulin- like growth factor binding protein-2 (IGFBP-2) in IEC-6 cells by transforming growth factor-β1 (TGF-β1) and insulin and to determine whether IGFBP-2 mediated the growth-inhibitory action on the cells. Utilizing Western ligand blot analysis, we found that TGF-β1 at concentrations of 0.5, 1.0, and 2 ng/ml significantly increased levels of 32-kDa IGFBP in the conditioned medium (CM) of IEC-6 cells in a dose-dependent fashion and that low doses of insulin (1.0 and 5.0 μg/ml) also increased IGFBP levels in the CM of IEC-6 cells, but a high dose of insulin (10 μg/ml) depressed IGFBP release in the CM. Immunoblotting has shown that the IGFBP of 32 kDa was IGFBP-2 and further confirmed the above results. IGFBP-2 mRNA levels were stimulated by TGF-β1 (2.0 ng/ml) and suppressed by insulin (5.0 μg/ml). In addition, des (1-3) IGF-I (50 ng/ml) and insulin stimulated the proliferation of IEC-6 cells. Anti-IGFBP-2 antibodies partially blocked the inhibitory role in IEC-6 cell growth evoked by des (1-3) IGF-I. These findings suggest that the upregulation of IGFBP-2 by TGF-β1 occurs, at least in part, at the level of mRNA, whereas the regulation by insulin appears to be at a posttranslational level, and that the TGF-β1-stimulated production of IGFBP may contribute to the growth-inhibitory action in intestinal epithelial cells.",
keywords = "transforming growth factor-β1",
author = "Guo, {Y. S.} and Courtney Townsend and Jin, {G. F.} and Beauchamp, {R. D.} and Thompson, {J. C.}",
year = "1995",
language = "English (US)",
volume = "268",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6 31-6",

}

TY - JOUR

T1 - Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells

AU - Guo, Y. S.

AU - Townsend, Courtney

AU - Jin, G. F.

AU - Beauchamp, R. D.

AU - Thompson, J. C.

PY - 1995

Y1 - 1995

N2 - The purposes of this study were to determine the regulation of insulin- like growth factor binding protein-2 (IGFBP-2) in IEC-6 cells by transforming growth factor-β1 (TGF-β1) and insulin and to determine whether IGFBP-2 mediated the growth-inhibitory action on the cells. Utilizing Western ligand blot analysis, we found that TGF-β1 at concentrations of 0.5, 1.0, and 2 ng/ml significantly increased levels of 32-kDa IGFBP in the conditioned medium (CM) of IEC-6 cells in a dose-dependent fashion and that low doses of insulin (1.0 and 5.0 μg/ml) also increased IGFBP levels in the CM of IEC-6 cells, but a high dose of insulin (10 μg/ml) depressed IGFBP release in the CM. Immunoblotting has shown that the IGFBP of 32 kDa was IGFBP-2 and further confirmed the above results. IGFBP-2 mRNA levels were stimulated by TGF-β1 (2.0 ng/ml) and suppressed by insulin (5.0 μg/ml). In addition, des (1-3) IGF-I (50 ng/ml) and insulin stimulated the proliferation of IEC-6 cells. Anti-IGFBP-2 antibodies partially blocked the inhibitory role in IEC-6 cell growth evoked by des (1-3) IGF-I. These findings suggest that the upregulation of IGFBP-2 by TGF-β1 occurs, at least in part, at the level of mRNA, whereas the regulation by insulin appears to be at a posttranslational level, and that the TGF-β1-stimulated production of IGFBP may contribute to the growth-inhibitory action in intestinal epithelial cells.

AB - The purposes of this study were to determine the regulation of insulin- like growth factor binding protein-2 (IGFBP-2) in IEC-6 cells by transforming growth factor-β1 (TGF-β1) and insulin and to determine whether IGFBP-2 mediated the growth-inhibitory action on the cells. Utilizing Western ligand blot analysis, we found that TGF-β1 at concentrations of 0.5, 1.0, and 2 ng/ml significantly increased levels of 32-kDa IGFBP in the conditioned medium (CM) of IEC-6 cells in a dose-dependent fashion and that low doses of insulin (1.0 and 5.0 μg/ml) also increased IGFBP levels in the CM of IEC-6 cells, but a high dose of insulin (10 μg/ml) depressed IGFBP release in the CM. Immunoblotting has shown that the IGFBP of 32 kDa was IGFBP-2 and further confirmed the above results. IGFBP-2 mRNA levels were stimulated by TGF-β1 (2.0 ng/ml) and suppressed by insulin (5.0 μg/ml). In addition, des (1-3) IGF-I (50 ng/ml) and insulin stimulated the proliferation of IEC-6 cells. Anti-IGFBP-2 antibodies partially blocked the inhibitory role in IEC-6 cell growth evoked by des (1-3) IGF-I. These findings suggest that the upregulation of IGFBP-2 by TGF-β1 occurs, at least in part, at the level of mRNA, whereas the regulation by insulin appears to be at a posttranslational level, and that the TGF-β1-stimulated production of IGFBP may contribute to the growth-inhibitory action in intestinal epithelial cells.

KW - transforming growth factor-β1

UR - http://www.scopus.com/inward/record.url?scp=0028887606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028887606&partnerID=8YFLogxK

M3 - Article

C2 - 7541944

AN - SCOPUS:0028887606

VL - 268

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 6 31-6

ER -